ANMerge: A comprehensive and accessible Alzheimer’s disease patient-level dataset

Manuscript Number: 

20-0948R2

Author(s): 
Colin Birkenbihl, Martin Hofmann-Apitius, Simon Lovestone, Alejo Nevado-Holgado, Liu Shi, Eric Westman, Sarah Westwood

Disclosures

Colin Birkenbihl

  • Nothing to Disclose

Martin Hofmann-Apitius

  • Nothing to Disclose

Simon Lovestone

  • Consulting Fees:
    In the past five years, consultancy for: Eisai, Merck, Optum labs
    Equity:
    Stock options in Akrivia Health (founding director) and J&J (employee)

Alejo Nevado-Holgado

  • Grants
    • Agency: 
      Johnson and Johnson
      Dates: 
      2018 onwards
    • Agency: 
      Ono Pharma
      Dates: 
      2018 onwards

Liu Shi

  • Nothing to Disclose

Eric Westman

  • Nothing to Disclose

Sarah Westwood

  • Nothing to Disclose